(SMMT) Summit Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Summit Therapeutics | (SMMT) share price targets
Complete technical analysis of Summit Therapeutics (SMMT) by charts plus indicators, forecast predictions and share price targets for Summit Therapeutics (SMMT)
Summit Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Summit Therapeutics is 1745830
| Date | Daily Closing Price | Open | High | Low | Volume |
| 18 Thu Apr 2024 | 3.51 | 3.61 | 3.67 | 3.50 | 0.718 times |
| 17 Wed Apr 2024 | 3.57 | 3.57 | 3.63 | 3.47 | 0.786 times |
| 16 Tue Apr 2024 | 3.54 | 3.61 | 3.61 | 3.49 | 0.717 times |
| 15 Mon Apr 2024 | 3.66 | 3.69 | 3.80 | 3.62 | 0.508 times |
| 12 Fri Apr 2024 | 3.67 | 4.01 | 4.07 | 3.63 | 0.78 times |
| 11 Thu Apr 2024 | 4.03 | 4.04 | 4.18 | 3.94 | 0.763 times |
| 10 Wed Apr 2024 | 4.00 | 3.92 | 4.12 | 3.90 | 1.829 times |
| 09 Tue Apr 2024 | 4.08 | 3.94 | 4.18 | 3.93 | 0.972 times |
| 08 Mon Apr 2024 | 3.95 | 3.90 | 4.06 | 3.80 | 0.911 times |
| 05 Fri Apr 2024 | 3.88 | 3.51 | 3.88 | 3.45 | 1.395 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 3.5 as stoploss in an intra day buy trade for a target of 3.75. However, stock will show a bearish move below 3.5.
Share price targets for Summit Therapeutics (SMMT)
| Target Type | Value |
| Downside Target | 1.93 |
| Downside Target | 2.53 |
| Downside Target | 2.87 |
| Downside Target | 3.25 |
| Downside Target | 3.42 |
| Upside Target | 3.63 |
| Upside Target | 3.80 |
| Upside Target | 4.18 |
| Upside Target | 4.24 |
| Upside Target | 4.56 |
| Upside Target | 4.64 |
| Upside Target | 4.72 |
| Upside Target | 5.14 |
| Upside Target | 5.22 |
Intraday share price targets for Summit Therapeutics (SMMT)
| Target Type | Value |
| Downside Intraday Target | 3.39 |
| Downside Intraday Target | 3.26 |
| Upside Intraday Target | 3.72 |
| Upside Intraday Target | 3.92 |
| Upside Intraday Target | 3.59 |
Weekly technical analysis of Summit Therapeutics (SMMT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 18 Thu Apr 2024 | 3.51 | 3.69 | 3.80 | 3.47 | 0.52 times |
| 12 Fri Apr 2024 | 3.67 | 3.90 | 4.18 | 3.63 | 0.928 times |
| 05 Fri Apr 2024 | 3.88 | 4.21 | 4.24 | 3.45 | 0.815 times |
| 28 Thu Mar 2024 | 4.14 | 3.44 | 4.64 | 3.27 | 0.889 times |
| 22 Fri Mar 2024 | 3.37 | 4.49 | 4.56 | 3.25 | 0.706 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Summit Therapeutics (SMMT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 18 Thu Apr 2024 | 3.51 | 4.21 | 4.24 | 3.45 | 0.429 times |
| 28 Thu Mar 2024 | 4.14 | 4.56 | 5.22 | 3.25 | 1.369 times |
| 29 Thu Feb 2024 | 4.54 | 3.94 | 5.14 | 3.42 | 0.836 times |
| 31 Wed Jan 2024 | 3.92 | 2.58 | 4.72 | 2.53 | 1.575 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Summit Therapeutics (SMMT)
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.83 and Summit Therapeutics (SMMT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.83 and Summit Therapeutics (SMMT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.